Recently, intranasal delivery of interleukin-4 (IL-4)-loaded lecithin-based liposomes was shown to enhance white matter integrity and attenuate long-term sensorimotor and cognitive deficits in MCAO models [97]. Here, IL4 is linked to Cognitive impairment.